Review



primary antibody against e2f3 sc-878  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology primary antibody against e2f3 sc-878
    <t>E2F3</t> was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.
    Primary Antibody Against E2f3 Sc 878, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against e2f3 sc-878/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against e2f3 sc-878 - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3"

    Article Title: miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2016.5901

    E2F3 was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.
    Figure Legend Snippet: E2F3 was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.

    Techniques Used: Binding Assay, Transfection, Luciferase, Activity Assay, Construct, Control, Standard Deviation, Mutagenesis

    miR-34a and siE2F3 reduce E2F3 expression. SRA01/04 cells transfected with miR-34a mimic or siE2F3 exhibited reduced E2F3 expression compared with the mock and mimic control. Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; si, small interfering; NS, non-significant.
    Figure Legend Snippet: miR-34a and siE2F3 reduce E2F3 expression. SRA01/04 cells transfected with miR-34a mimic or siE2F3 exhibited reduced E2F3 expression compared with the mock and mimic control. Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; si, small interfering; NS, non-significant.

    Techniques Used: Expressing, Transfection, Control, Standard Deviation



    Similar Products

    93
    Proteintech e2f3 primary antibodies
    <t>E2F3</t> is a miR-194-5p target gene in TE2 and KYSE150 cells A Predicted partially complementary binding sequence between E2F3 mRNA and miR-194-5p B Dual-luciferase reporter assays confirming miR-194-5p binding to the E2F3 3’UTR. C Pull-down assay was used to confirm the interaction of E2F3 and miR-194-5p D Western blot analysis of E2F3 protein levels in TE2 cells after miR-194-5p overexpression. * P < 0.05
    E2f3 Primary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2f3 primary antibodies/product/Proteintech
    Average 93 stars, based on 1 article reviews
    e2f3 primary antibodies - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Proteintech anti e2f3 primary antibody
    <t>E2F3</t> is a miR-194-5p target gene in TE2 and KYSE150 cells A Predicted partially complementary binding sequence between E2F3 mRNA and miR-194-5p B Dual-luciferase reporter assays confirming miR-194-5p binding to the E2F3 3’UTR. C Pull-down assay was used to confirm the interaction of E2F3 and miR-194-5p D Western blot analysis of E2F3 protein levels in TE2 cells after miR-194-5p overexpression. * P < 0.05
    Anti E2f3 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti e2f3 primary antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti e2f3 primary antibody - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    Proteintech primary anti e2f3 antibody
    The impact of Brevilin A on lncRNA H19, miR-194, and <t>E2F3</t> expressions. DU145 cells were treated at the concentrations of 10 μM and 20 μM, which were calculated through the IC 50 values of Brevilin A. ( A – I ) qRT-PCR determined lncRNA H19 ( A – C ), miR-194 ( D – F ) and E2F3 mRNA ( G – I ) expressions. ( J – L ) Western blot measured E2F3 expression. * P < 0.05, ** P < 0.01, *** P < 0.001 (vs. control), n = 3.
    Primary Anti E2f3 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary anti e2f3 antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary anti e2f3 antibody - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Proteintech primary antibodies against human ccnd1, cdk6, ccne2, e2f3, or met
    The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes <t>(i.e.,</t> <t>CCND1</t> , CDK6 , CCNE2 , E2F3 , <t>MET</t> , or FOSL1 ) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01).
    Primary Antibodies Against Human Ccnd1, Cdk6, Ccne2, E2f3, Or Met, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against human ccnd1, cdk6, ccne2, e2f3, or met/product/Proteintech
    Average 90 stars, based on 1 article reviews
    primary antibodies against human ccnd1, cdk6, ccne2, e2f3, or met - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    ZSGB Biotech primary antibody e2f3
    The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes <t>(i.e.,</t> <t>CCND1</t> , CDK6 , CCNE2 , E2F3 , <t>MET</t> , or FOSL1 ) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01).
    Primary Antibody E2f3, supplied by ZSGB Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody e2f3/product/ZSGB Biotech
    Average 90 stars, based on 1 article reviews
    primary antibody e2f3 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-e2f3 primary antibody
    The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes <t>(i.e.,</t> <t>CCND1</t> , CDK6 , CCNE2 , E2F3 , <t>MET</t> , or FOSL1 ) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01).
    Anti E2f3 Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-e2f3 primary antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-e2f3 primary antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary antibody against e2f3 sc-878
    <t>E2F3</t> was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.
    Primary Antibody Against E2f3 Sc 878, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against e2f3 sc-878/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against e2f3 sc-878 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology e2f3 primary antibody sc-878
    <t>E2F3</t> was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.
    E2f3 Primary Antibody Sc 878, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2f3 primary antibody sc-878/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    e2f3 primary antibody sc-878 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology e2f3 primary antibody (sc-878)
    JQ1 alters cyclin <t>D1-CDK4-Rb-E2F3</t> signaling and AT2A/HEXIM1 abundance in thyroid tumors of ThrbPV/PVKrasG12D mice. (A-I) Total protein extracts were prepared from thyroid tumors. Western blot analysis was carried out for p-Rb(S780) (a), total Rb (b), E3F3 (c), CDK4 (d), cyclin D1 (e), KAT2A (f), HEXIM1 (g), and GAPDH (h), as described in Materials and Methods. (A-II) Quantitative analysis of relative protein expression levels of the ratio of p-Rb(S780) to total Rb (a), E3F3 (b), CDK4 (c), cyclin D1 (d), KAT2A (e), HEXIM1 (f) in mice treated with vehicle or JQ1. (B). Decreased Kat2a (panel a) and increased Hexim1 (panel b) mRNA expression in thyroid tumors of ThrbPV/PVKrasG12D mice treated with JQ1. Total RNAs prepared from thyroid tumors of the ThrbPV/PVKrasG12D mice treated with vehicle or JQ1 were used for the analysis of RNA expression.
    E2f3 Primary Antibody (Sc 878), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2f3 primary antibody (sc-878)/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    e2f3 primary antibody (sc-878) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    E2F3 is a miR-194-5p target gene in TE2 and KYSE150 cells A Predicted partially complementary binding sequence between E2F3 mRNA and miR-194-5p B Dual-luciferase reporter assays confirming miR-194-5p binding to the E2F3 3’UTR. C Pull-down assay was used to confirm the interaction of E2F3 and miR-194-5p D Western blot analysis of E2F3 protein levels in TE2 cells after miR-194-5p overexpression. * P < 0.05

    Journal: World Journal of Surgical Oncology

    Article Title: Circ_0001741 regulates proliferation and invasion in ESCC via the miR-194-5p/E2F3 axis

    doi: 10.1186/s12957-025-04124-2

    Figure Lengend Snippet: E2F3 is a miR-194-5p target gene in TE2 and KYSE150 cells A Predicted partially complementary binding sequence between E2F3 mRNA and miR-194-5p B Dual-luciferase reporter assays confirming miR-194-5p binding to the E2F3 3’UTR. C Pull-down assay was used to confirm the interaction of E2F3 and miR-194-5p D Western blot analysis of E2F3 protein levels in TE2 cells after miR-194-5p overexpression. * P < 0.05

    Article Snippet: Membranes were incubated overnight at 4 °C with E2F3 primary antibodies (Proteintech, China, Cat No. 27615-1-AP), followed by HRP-conjugated secondary antibodies (Proteintech, China).

    Techniques: Binding Assay, Sequencing, Luciferase, Pull Down Assay, Western Blot, Over Expression

    E2F3 overexpression reverses the effects of circ_0001741 knockdown A E2F3 overexpression partially rescues the anti-invasive effects of si-circ_0001741 or miR-194-5p in TE2 and KYSE150 cells B E2F3 overexpression partially restores proliferation suppressed by si-circ_0001741 or miR-194-5p. * P < 0.05

    Journal: World Journal of Surgical Oncology

    Article Title: Circ_0001741 regulates proliferation and invasion in ESCC via the miR-194-5p/E2F3 axis

    doi: 10.1186/s12957-025-04124-2

    Figure Lengend Snippet: E2F3 overexpression reverses the effects of circ_0001741 knockdown A E2F3 overexpression partially rescues the anti-invasive effects of si-circ_0001741 or miR-194-5p in TE2 and KYSE150 cells B E2F3 overexpression partially restores proliferation suppressed by si-circ_0001741 or miR-194-5p. * P < 0.05

    Article Snippet: Membranes were incubated overnight at 4 °C with E2F3 primary antibodies (Proteintech, China, Cat No. 27615-1-AP), followed by HRP-conjugated secondary antibodies (Proteintech, China).

    Techniques: Over Expression, Knockdown

    The impact of Brevilin A on lncRNA H19, miR-194, and E2F3 expressions. DU145 cells were treated at the concentrations of 10 μM and 20 μM, which were calculated through the IC 50 values of Brevilin A. ( A – I ) qRT-PCR determined lncRNA H19 ( A – C ), miR-194 ( D – F ) and E2F3 mRNA ( G – I ) expressions. ( J – L ) Western blot measured E2F3 expression. * P < 0.05, ** P < 0.01, *** P < 0.001 (vs. control), n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The impact of Brevilin A on lncRNA H19, miR-194, and E2F3 expressions. DU145 cells were treated at the concentrations of 10 μM and 20 μM, which were calculated through the IC 50 values of Brevilin A. ( A – I ) qRT-PCR determined lncRNA H19 ( A – C ), miR-194 ( D – F ) and E2F3 mRNA ( G – I ) expressions. ( J – L ) Western blot measured E2F3 expression. * P < 0.05, ** P < 0.01, *** P < 0.001 (vs. control), n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Quantitative RT-PCR, Western Blot, Expressing, Control

    The profiles of lncRNA H19, miR-194, and E2F3 in prostate cancer tissues and cell lines. ( A , B ) qRT-PCR detected lncRNA H19 expression in prostate cancer tissues and cell lines. ( C , D ) qRT-PCR determined miR-194 expression in prostate cancer tissues and cell lines. ( E , F ) qRT-PCR examined E2F3 mRNA expression in prostate cancer tissues and cell lines. ( G , H ) Western blot was performed for assaying E2F3 protein level. ( I ) Immunohistochemistry checked E2F3 expression in prostate cancer tissues. Scale bar = 50 μm. * P < 0.05, ** P < 0.01, *** P < 0.001 (vs. Normal or PrEC), n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The profiles of lncRNA H19, miR-194, and E2F3 in prostate cancer tissues and cell lines. ( A , B ) qRT-PCR detected lncRNA H19 expression in prostate cancer tissues and cell lines. ( C , D ) qRT-PCR determined miR-194 expression in prostate cancer tissues and cell lines. ( E , F ) qRT-PCR examined E2F3 mRNA expression in prostate cancer tissues and cell lines. ( G , H ) Western blot was performed for assaying E2F3 protein level. ( I ) Immunohistochemistry checked E2F3 expression in prostate cancer tissues. Scale bar = 50 μm. * P < 0.05, ** P < 0.01, *** P < 0.001 (vs. Normal or PrEC), n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Quantitative RT-PCR, Expressing, Western Blot, Immunohistochemistry

    The interaction among lncRNA H19, miR-194, and E2F3. ( A , B ) Starbase database the binding site between lncRNA H19 and miR-194 as well as the binding site between miR-194 and E2F3. ( C – F ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( G , H ) Dual luciferase reporter gene assay measured luciferase activity of DU145 cells. ( I , J ) The miR-194 level was probed via qRT-PCR. ( K – R ) Western blot and qRT-PCR tested the effects of lncRNA H19 and miR-194 on E2F3 expression. ns P > 0.05, *** P < 0.001, n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The interaction among lncRNA H19, miR-194, and E2F3. ( A , B ) Starbase database the binding site between lncRNA H19 and miR-194 as well as the binding site between miR-194 and E2F3. ( C – F ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( G , H ) Dual luciferase reporter gene assay measured luciferase activity of DU145 cells. ( I , J ) The miR-194 level was probed via qRT-PCR. ( K – R ) Western blot and qRT-PCR tested the effects of lncRNA H19 and miR-194 on E2F3 expression. ns P > 0.05, *** P < 0.001, n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Binding Assay, Quantitative RT-PCR, Luciferase, Reporter Gene Assay, Activity Assay, Western Blot, Expressing

    The influence of lncRNA H19 and miR-194 on DU145 cell proliferation, apoptosis, invasion, and migration. H19 overexpression plasmids and si-H19 were transfected into DU145 cells, and miR-194 mimics or inhibitors were administered for 24 hours culture. ( A , B ) CCK8 assay detected cell proliferation. ( C , D ) Transwell monitored cell migration and invasion. Scale bar = 100 μm. ( E , F ) TUNEL staining examined apoptosis. Scale bar = 50 μm. ( G , H ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( I , J ) Western blot was used for examining E2F3 protein level. ** P < 0.01, *** P < 0.001 (vs. NC or siNC); && P < 0.01, &&& P < 0.001 (vs. H19 or siH19), n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The influence of lncRNA H19 and miR-194 on DU145 cell proliferation, apoptosis, invasion, and migration. H19 overexpression plasmids and si-H19 were transfected into DU145 cells, and miR-194 mimics or inhibitors were administered for 24 hours culture. ( A , B ) CCK8 assay detected cell proliferation. ( C , D ) Transwell monitored cell migration and invasion. Scale bar = 100 μm. ( E , F ) TUNEL staining examined apoptosis. Scale bar = 50 μm. ( G , H ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( I , J ) Western blot was used for examining E2F3 protein level. ** P < 0.01, *** P < 0.001 (vs. NC or siNC); && P < 0.01, &&& P < 0.001 (vs. H19 or siH19), n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Migration, Over Expression, Transfection, CCK-8 Assay, TUNEL Assay, Staining, Quantitative RT-PCR, Western Blot

    The impact of miR-194 and E2F3 on DU145 cell proliferation, apoptosis, invasion, and migration. E2F3 overexpression and si-E2F3 plasmids were transfected into DU145 cells for 24 hour culture after miR-194 mimics or inhibitors were administered. ( A , B ) CCK8 assay checked cell proliferation. ( C , D ) Transwell assay examined cell migration and invasion. Scale bar = 100 μm. ( E , F ) TUNEL staining detected cell apoptosis. Scale bar = 50 μm. ( G , H ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( I , J ) Western blot was used for examining E2F3 protein level. *** P < 0.001 (vs. NC or NC-in); & P < 0.05, && P < 0.01, &&& P < 0.001 (vs. miR-149 or miR-149 in), n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The impact of miR-194 and E2F3 on DU145 cell proliferation, apoptosis, invasion, and migration. E2F3 overexpression and si-E2F3 plasmids were transfected into DU145 cells for 24 hour culture after miR-194 mimics or inhibitors were administered. ( A , B ) CCK8 assay checked cell proliferation. ( C , D ) Transwell assay examined cell migration and invasion. Scale bar = 100 μm. ( E , F ) TUNEL staining detected cell apoptosis. Scale bar = 50 μm. ( G , H ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( I , J ) Western blot was used for examining E2F3 protein level. *** P < 0.001 (vs. NC or NC-in); & P < 0.05, && P < 0.01, &&& P < 0.001 (vs. miR-149 or miR-149 in), n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Migration, Over Expression, Transfection, CCK-8 Assay, Transwell Assay, TUNEL Assay, Staining, Quantitative RT-PCR, Western Blot

    Brevilin A hampered the pro-cancer function of lncRNA H19. Brevilin A was utilized to treat DU145 cells stably transfected with lncRNA H19 overexpression plasmids. ( A ) CCK8 assay checked cell proliferation. ( B ) Transwell assay examined cell migration and invasion. Scale bar = 100 μm. ( C ) TUNEL staining detected cell apoptosis. Scale bar = 50 μm. ( D , E ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( F ) Western blot was used for examining E2F3 protein level. ** P < 0.01, *** P < 0.001 (vs. NC); & P < 0.05, && P < 0.01, &&& P < 0.001 (vs. H19), n = 3.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: Brevilin A hampered the pro-cancer function of lncRNA H19. Brevilin A was utilized to treat DU145 cells stably transfected with lncRNA H19 overexpression plasmids. ( A ) CCK8 assay checked cell proliferation. ( B ) Transwell assay examined cell migration and invasion. Scale bar = 100 μm. ( C ) TUNEL staining detected cell apoptosis. Scale bar = 50 μm. ( D , E ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( F ) Western blot was used for examining E2F3 protein level. ** P < 0.01, *** P < 0.001 (vs. NC); & P < 0.05, && P < 0.01, &&& P < 0.001 (vs. H19), n = 3.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Stable Transfection, Transfection, Over Expression, CCK-8 Assay, Transwell Assay, Migration, TUNEL Assay, Staining, Quantitative RT-PCR, Western Blot

    The functions of Brevilin A and lncRNA H19 in the prostate cancer nude mouse xenograft model. DU145 cells, stably transfected with lncRNA H19 overexpression plasmids, were taken to construct a nude mouse xenograft model of prostate cancer, and Brevilin A was harnessed for treatment. The tumors were excised 28 days later. ( A ) The tumor volume. ( B ) The images of tumors. ( C ) The tumor masses. ( D , E ) Immunohistochemistry determined Ki67 and E2F3 expressions. ( F , G ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( H ) Western blot was used for examining E2F3 protein level. *** P < 0.001 (vs. NC); && P < 0.01, &&& P < 0.001 (vs. H19), n = 5.

    Journal: Aging (Albany NY)

    Article Title: Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway

    doi: 10.18632/aging.204744

    Figure Lengend Snippet: The functions of Brevilin A and lncRNA H19 in the prostate cancer nude mouse xenograft model. DU145 cells, stably transfected with lncRNA H19 overexpression plasmids, were taken to construct a nude mouse xenograft model of prostate cancer, and Brevilin A was harnessed for treatment. The tumors were excised 28 days later. ( A ) The tumor volume. ( B ) The images of tumors. ( C ) The tumor masses. ( D , E ) Immunohistochemistry determined Ki67 and E2F3 expressions. ( F , G ) qRT-PCR examined the profiles of lncRNA H19 and miR-194. ( H ) Western blot was used for examining E2F3 protein level. *** P < 0.001 (vs. NC); && P < 0.01, &&& P < 0.001 (vs. H19), n = 5.

    Article Snippet: Primary anti-E2F3 antibody (1:100) (Proteintech, Wuhan, China) or Ki67 antibody (1:100) (Abcam, ab15580, MA, USA) was added for maintaining at 4°C overnight.

    Techniques: Stable Transfection, Transfection, Over Expression, Construct, Immunohistochemistry, Quantitative RT-PCR, Western Blot

    The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes (i.e., CCND1 , CDK6 , CCNE2 , E2F3 , MET , or FOSL1 ) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01).

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer

    doi: 10.1016/j.omtn.2017.10.016

    Figure Lengend Snippet: The Mechanism of Shrimp miR-34 in Inhibiting Breast Cancer Progression (A) The prediction of genes targeted by shrimp miR-34. The seed sequence of miR-34 is underlined. (B) The direct interaction between shrimp miR-34 and its target genes (i.e., CCND1 , CDK6 , CCNE2 , E2F3 , MET , or FOSL1 ) in breast cancer cells (MDA-MB-231). Luciferase activity was normalized to the ratio of firefly and Renilla luciferase activities. (C) The effects of shrimp miR-34 expression on the expression of miR-34 target genes in breast cancer cells (MDA-MB-231 and MDA-MB-435). (D) The influence of shrimp miR-34 expression on the expression of miR-34 target gene-encoding proteins in breast cancer cells. Protein levels were detected using western blot analysis. As a control, miR-34-scrambled was included in the transfection. Tubulin was used as a loading control. (E) The loading of shrimp miR-34 onto the human Ago2 complex. Shrimp miR-34 was incubated with the human Ago2 complex, followed by EMSA. Shrimp miR-34 was visualized by ethidium bromide staining (top). Human Ago2 protein was detected with western blot analysis (bottom). The wedge indicates the concentration gradient of human Ago2 complex. (F) A model for the role of miR-34-mediated cancer cell growth and metastasis. In all panels, statistically significant differences between treatments are represented with asterisks (error bar, SD; *p < 0.05 and **p < 0.01).

    Article Snippet: The paraffin sections were then incubated with primary antibodies against human CCND1, CDK6, CCNE2, E2F3, or MET (Proteintech Group, USA) at 4°C overnight, followed by incubation with HRP-conjugated goat anti-Rabbit IgG (Sigma-Aldrich, USA) for 2 hr at room temperature.

    Techniques: Sequencing, Luciferase, Activity Assay, Expressing, Western Blot, Control, Transfection, Incubation, Staining, Concentration Assay

    E2F3 was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.

    Journal: Molecular Medicine Reports

    Article Title: miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3

    doi: 10.3892/mmr.2016.5901

    Figure Lengend Snippet: E2F3 was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.

    Article Snippet: Subsequent to blocking in Tris-buffered saline with Tween-20 (TBST) containing 25 mmol/l Tris-HCl, pH 7.5, 137 mmol/l NaCl, 2.7 mmol/l KCl and 0.05% Tween-20 with 5% nonfat milk for 1 h at 37°C, the membranes were incubated with the primary antibody against E2F3 (sc-878; 1:200; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) or GAPDH (ab9485; 1:2,500; Abcam, Cambridge, MA, USA) in TBST with 5% nonfat milk at 4°C overnight.

    Techniques: Binding Assay, Transfection, Luciferase, Activity Assay, Construct, Control, Standard Deviation, Mutagenesis

    miR-34a and siE2F3 reduce E2F3 expression. SRA01/04 cells transfected with miR-34a mimic or siE2F3 exhibited reduced E2F3 expression compared with the mock and mimic control. Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; si, small interfering; NS, non-significant.

    Journal: Molecular Medicine Reports

    Article Title: miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3

    doi: 10.3892/mmr.2016.5901

    Figure Lengend Snippet: miR-34a and siE2F3 reduce E2F3 expression. SRA01/04 cells transfected with miR-34a mimic or siE2F3 exhibited reduced E2F3 expression compared with the mock and mimic control. Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; si, small interfering; NS, non-significant.

    Article Snippet: Subsequent to blocking in Tris-buffered saline with Tween-20 (TBST) containing 25 mmol/l Tris-HCl, pH 7.5, 137 mmol/l NaCl, 2.7 mmol/l KCl and 0.05% Tween-20 with 5% nonfat milk for 1 h at 37°C, the membranes were incubated with the primary antibody against E2F3 (sc-878; 1:200; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) or GAPDH (ab9485; 1:2,500; Abcam, Cambridge, MA, USA) in TBST with 5% nonfat milk at 4°C overnight.

    Techniques: Expressing, Transfection, Control, Standard Deviation

    JQ1 alters cyclin D1-CDK4-Rb-E2F3 signaling and AT2A/HEXIM1 abundance in thyroid tumors of ThrbPV/PVKrasG12D mice. (A-I) Total protein extracts were prepared from thyroid tumors. Western blot analysis was carried out for p-Rb(S780) (a), total Rb (b), E3F3 (c), CDK4 (d), cyclin D1 (e), KAT2A (f), HEXIM1 (g), and GAPDH (h), as described in Materials and Methods. (A-II) Quantitative analysis of relative protein expression levels of the ratio of p-Rb(S780) to total Rb (a), E3F3 (b), CDK4 (c), cyclin D1 (d), KAT2A (e), HEXIM1 (f) in mice treated with vehicle or JQ1. (B). Decreased Kat2a (panel a) and increased Hexim1 (panel b) mRNA expression in thyroid tumors of ThrbPV/PVKrasG12D mice treated with JQ1. Total RNAs prepared from thyroid tumors of the ThrbPV/PVKrasG12D mice treated with vehicle or JQ1 were used for the analysis of RNA expression.

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Bromodomain and extraterminal protein inhibitor JQ1 suppresses thyroid tumor growth in a mouse model

    doi: 10.1158/1078-0432.CCR-16-0914

    Figure Lengend Snippet: JQ1 alters cyclin D1-CDK4-Rb-E2F3 signaling and AT2A/HEXIM1 abundance in thyroid tumors of ThrbPV/PVKrasG12D mice. (A-I) Total protein extracts were prepared from thyroid tumors. Western blot analysis was carried out for p-Rb(S780) (a), total Rb (b), E3F3 (c), CDK4 (d), cyclin D1 (e), KAT2A (f), HEXIM1 (g), and GAPDH (h), as described in Materials and Methods. (A-II) Quantitative analysis of relative protein expression levels of the ratio of p-Rb(S780) to total Rb (a), E3F3 (b), CDK4 (c), cyclin D1 (d), KAT2A (e), HEXIM1 (f) in mice treated with vehicle or JQ1. (B). Decreased Kat2a (panel a) and increased Hexim1 (panel b) mRNA expression in thyroid tumors of ThrbPV/PVKrasG12D mice treated with JQ1. Total RNAs prepared from thyroid tumors of the ThrbPV/PVKrasG12D mice treated with vehicle or JQ1 were used for the analysis of RNA expression.

    Article Snippet: The E2F3 primary antibody (sc-878) and Rb (sc-50) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

    Techniques: Western Blot, Expressing, RNA Expression